Planning Capital Management Corporation’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.68K Hold
7,272
﹤0.01% 606
2024
Q2
$3.95K Hold
7,272
﹤0.01% 480
2024
Q1
$7.42K Hold
7,272
0.01% 447
2023
Q4
$4.15K Buy
+7,272
New +$4.15K ﹤0.01% 504